Odysseas Kostas D has filed 17 insider transactions across 3 companies since May 2023.
Most recent transaction: a grant/award of 25640 shares of Armata Pharmaceuticals, Inc. ($ARMP) on March 09, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 9, 2026 | Armata Pharmaceuticals, Inc. | $ARMP | Odysseas Kostas D | Director | A | Stock Options (Right to Buy) | 25640 | $0.00 | 25,640.0000 | 36,226,285 | 9999.99% | 0.07% |
| April 18, 2025 | AMARIN CORP PLCUK | $AMRN | Odysseas Kostas D | Not found | M | American Depositary Shares | 838 | $0.00 | 838.0000 | 411,584,851 | 9999.99% | 0.00% |
| April 18, 2025 | AMARIN CORP PLCUK | $AMRN | Odysseas Kostas D | Not found | F | American Depositary Shares | 437 | $9.11 | 401.0000 | 411,584,851 | 52.15% | 0.00% |
| April 18, 2025 | AMARIN CORP PLCUK | $AMRN | Odysseas Kostas D | Not found | M | Restricted Stock Unit | 838 | $0.00 | 1,676.0000 | 411,584,851 | 100.00% | 0.00% |
| Feb. 5, 2025 | Armata Pharmaceuticals, Inc. | $ARMP | Odysseas Kostas D | Director | A | Stock Options (Right to Buy) | 54343 | $0.00 | 54,343.0000 | 59,059,971 | 9999.99% | 0.09% |
| June 17, 2024 | Innoviva, Inc. | $INVA | Odysseas Kostas D | Director | A | Common Stock | 13923 | $0.00 | 122,625.0000 | 86,876,000 | 12.81% | 0.02% |
| June 17, 2024 | Innoviva, Inc. | $INVA | Odysseas Kostas D | Director | A | Non-statutory Stock Option | 10000 | $0.00 | 30,000.0000 | 86,876,000 | 50.00% | 0.01% |
| April 18, 2024 | AMARIN CORP PLCUK | $AMRN | Odysseas Kostas D | Not found | A | Restricted Stock Unit | 50287 | $0.00 | 50,287.0000 | 408,824,093 | 9999.99% | 0.01% |
| April 18, 2024 | AMARIN CORP PLCUK | $AMRN | Odysseas Kostas D | Not found | A | Stock Option (right to buy) | 179795 | $0.00 | 179,795.0000 | 408,824,093 | 9999.99% | 0.04% |
| March 14, 2024 | Armata Pharmaceuticals, Inc. | $ARMP | Odysseas Kostas D | Director | A | Stock Options (Right to Buy) | 54343 | $0.00 | 94,009.0000 | 36,075,555 | 137.00% | 0.15% |
| March 14, 2024 | Armata Pharmaceuticals, Inc. | $ARMP | Odysseas Kostas D | Director | A | Stock Options (Right to Buy) | 39666 | $0.00 | 39,666.0000 | 36,075,555 | 9999.99% | 0.11% |
| July 21, 2023 | AMARIN CORP PLCUK | $AMRN | Odysseas Kostas D | Not found | A | Stock Option (Right to Buy) | 180804 | $0.00 | 180,804.0000 | 408,824,093 | 9999.99% | 0.04% |
| July 21, 2023 | AMARIN CORP PLCUK | $AMRN | Odysseas Kostas D | Not found | A | Restricted Stock Units | 94866 | $0.00 | 94,866.0000 | 408,824,093 | 9999.99% | 0.02% |
| July 21, 2023 | AMARIN CORP PLCUK | $AMRN | Odysseas Kostas D | Not found | A | Restricted Stock Units | 60268 | $0.00 | 60,268.0000 | 408,824,093 | 9999.99% | 0.01% |
| July 21, 2023 | AMARIN CORP PLCUK | $AMRN | Odysseas Kostas D | Not found | A | Stock Option (Right to Buy) | 258598 | $0.00 | 284,598.0000 | 408,824,093 | 994.61% | 0.06% |
| May 22, 2023 | Innoviva, Inc. | $INVA | Odysseas Kostas D | Director | A | Common Stock | 16495 | $0.00 | 108,702.0000 | 95,248,000 | 17.89% | 0.02% |
| May 22, 2023 | Innoviva, Inc. | $INVA | Odysseas Kostas D | Director | A | Non-statutory Stock Option | 10000 | $0.00 | 20,000.0000 | 95,248,000 | 100.00% | 0.01% |